Feasibility study of adjuvant chemotherapy with TS-1 followed by DCS (DTX+CDDP+S-1) for stage III gastric cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions
- 01 Oct 2021 Results assessing feasibility, safety, and efficacy of postoperative adjuvant chemotherapy with docetaxel/cisplatin/S-1 (DCS) following S-1 therapy in patients with stage III gastric cancer after curative gastrectomypublished in the BMC Cancer
- 06 Feb 2014 New trial record